Professor at Karolinska Institutet since 1998, firstly of Neurophysiology and, as of 2007, of Integrative Medicine as well as leading research activities at the Osher Center for Integrative Medicine.
Deputy Vice-Chancellor at Karolinska Institutet with special focus on issues concerning the healthcare of the future since 2014.
Docent (Associate Professor) 1984 at Lund University in experimental neurological research. Docent 1992 at Karolinska Institutet in Clinical Neurophysiology.
2013- Chairman of the board Swedish Research Council for health, working life and welfare (Forte)
2014- Chairman of the board Swelife – a strategic initiative within life science
2010-2013 Dean of Research, Karolinska Institutet.
2004-2010 Head of Department for Clinical Neuroscience.
2001-2004 Deputy Head of Department for Clinical Neuroscience
2002-2006 Chair of the Board for World Childhood Foundation.
1996-2002 Coordinator for Karolinska PET. Since 1998 Director of Karolinska MR Center and, since 2006
- Medical Degree at Lund University 1984
- Doctor of Medical Science at Lund University in 1982 in experimental neurological research.
Our research arena in cognitive neuroscience consists of several groups. We host the Osher Center for Integrative Medicine, the MR Research Center which focuses on structural and functional imaging of the human brain and also the national MEG infrastructure. The accent of my research is placed on pain and emotional modulation in the forebrain. The methodological span extends from the gene to behaviour.
The Osher Center for Integrative Medicine whose purpose is to enhance knowledge through scientific methods of those mechanisms that are utilised in patient treatment both in ordinary healthcare activities and within alternative/complementary medicine.
At the Osher Center it has been demonstrated that many complementary therapies rest on placebo mechanisms that can be demonstrated both in the nervous system and the immune system in interaction. One good example is that regulating pain in fibromyalgia has reduced capacity and that the reduction co-varies with a diminished activity in the brain’s system for top-down pain modulation.